A new trading day began on Friday, with Prime Medicine Inc (NASDAQ: PRME) stock price down -5.59% from the previous day of trading, before settling in for the closing price of $5.19. PRME’s price has ranged from $4.11 to $15.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -25.00%. Meanwhile, its annual earnings per share averaged 25.01%. With a float of $50.59 million, this company’s outstanding shares have now reached $97.38 million.
The extent of productivity of a business whose workforce counts for 234 workers is very important to gauge.
Prime Medicine Inc (PRME) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Prime Medicine Inc is 57.85%, while institutional ownership is 37.42%. The most recent insider transaction that took place on Feb 15 ’24, was worth 20,000,000. In this transaction 10% Owner of this company bought 3,200,000 shares at a rate of $6.25, taking the stock ownership to the 3,200,000 shares. Before that another transaction happened on Feb 15 ’24, when Company’s 10% Owner bought 3,200,000 for $6.25, making the entire transaction worth $20,000,000. This insider now owns 3,200,000 shares in total.
Prime Medicine Inc (PRME) Performance Highlights and Predictions
In its latest quarterly report, released on 3/31/2024, the company reported earnings of -0.47 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.01% per share during the next fiscal year.
Prime Medicine Inc (NASDAQ: PRME) Trading Performance Indicators
Here are Prime Medicine Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 996.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.13, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.51 in one year’s time.
Technical Analysis of Prime Medicine Inc (PRME)
The latest stats from [Prime Medicine Inc, PRME] show that its last 5-days average volume of 0.61 million was inferior to 0.79 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 25.53%. Additionally, its Average True Range was 0.48.
During the past 100 days, Prime Medicine Inc’s (PRME) raw stochastic average was set at 18.99%, which indicates a significant increase from 7.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.23% in the past 14 days, which was higher than the 88.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.09, while its 200-day Moving Average is $6.87. Now, the first resistance to watch is $5.13. This is followed by the second major resistance level at $5.37. The third major resistance level sits at $5.55. If the price goes on to break the first support level at $4.71, it is likely to go to the next support level at $4.53. Assuming the price breaks the second support level, the third support level stands at $4.29.
Prime Medicine Inc (NASDAQ: PRME) Key Stats
With a market capitalization of 588.15 million, the company has a total of 120,031K Shares Outstanding. Currently, annual sales are 0 K while annual income is -198,130 K. The company’s previous quarter sales were 590 K while its latest quarter income was -45,760 K.
